reference/11189162

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11189162

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	2355
issn	0269-9370
issueIdentifier	16
pageRange	2351-2355
publicationName	AIDS (London, England)
startingPage	2351
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8754996ed0287cb6147c649371cdb6f7
bibliographicCitation	Vuola JM, Ristola MA, Cole B, Järviluoma A, Tvaroha S, Rönkkö T, Rautio O, Arbeit RD, von Reyn CF. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial. AIDS. 2003 Nov 07;17(16):2351–5. doi: 10.1097/00002030-200311070-00010. PMID: 14571187.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ed70b46210c1e00888ed5b9682d5fc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c74880b355b6443afd17c24cd84bad02 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6314614a230634a17085766b7bdaa1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e39486e9ad9fb571e19296b0027f1a5e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a045e5bc733d101aa17dff96b119818 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80bb0a74f2d180a883c614a6e463d596 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f9c5b3f3205bc4b49faadd437b35717 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a90be34b827e18ddb6269a983752feb1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2ff0bf7b0f55771eadd98b005a6e20a
date	2003-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/14571187 https://doi.org/10.1097/00002030-200311070-00010
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1493 https://portal.issn.org/resource/ISSN/0269-9370
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0002239 http://id.nlm.nih.gov/mesh/M0002240 http://id.nlm.nih.gov/mesh/M0023305 http://id.nlm.nih.gov/mesh/M0011490
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014376Q000517 http://id.nlm.nih.gov/mesh/D032581Q000276 http://id.nlm.nih.gov/mesh/D015658Q000150 http://id.nlm.nih.gov/mesh/D009894Q000517
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015658Q000276 http://id.nlm.nih.gov/mesh/D008213Q000276 http://id.nlm.nih.gov/mesh/D009161Q000276 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014376Q000150 http://id.nlm.nih.gov/mesh/D007371Q000096 http://id.nlm.nih.gov/mesh/D009894Q000150 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D018791 http://id.nlm.nih.gov/mesh/D004306 http://id.nlm.nih.gov/mesh/D001500 http://id.nlm.nih.gov/mesh/D007111 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015164Q000276 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d2eac63192f2d6e4b9b95cd225e2ba7 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9505

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395

Total number of triples: 56.